Intrinsiqs

Is United Therapeutics Corporation overvalued?

United Therapeutics Corporation (UTHR) looks overvalued — trading about 16% above its fair value.

Overvalued
Current price $511.72 Fair value $429.99
Price
$511.72
Fair value
$429.99
Current P/E
18.9
Normal P/E
15.9
Market cap
$21.72B
Dividend yield
0.0%
Return on equity
20.2%
Sector
Healthcare

See the full interactive analysis →

Fair value compares UTHR's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.UNH UnitedHealth Group IncorporatedRHHBY Roche Holding AGMRK Merck & Co., Inc.